Acute Spinal Cord Injury Related Antibodies
Spinal cord injury (SCI) can be divided into primary and secondary injuries based on the mechanism of injury. The former is caused by the initial external force acting directly or indirectly on the spinal cord, while the latter is based on a series of physiological and biochemical mechanisms, such as oxidative stress, inflammatory response and excessive release of excitatory amino acids, which cause the intact tissue around the lesion to undergo self-destructive lesions, further deepening the degree of injury and expanding the area of injury.
Key Factors of SCI
-
Inflammasome
The inflammatory response is the major pathological process in the secondary injury phase. In the acute phase, reducing secondary injury by inhibiting neuroinflammation is believed to reduce damage to nerve function and achieve neuroprotection. A class of protein complexes known as inflammasome is primarily scaffolded by pattern recognition receptors from the PHYIN and NLR families as well as other receptor proteins. Some examples of common inflammasomes are AIM2, NLRP1, NLRP3, and NLRC4 (IPAF).
Cat. No | Product Name | Host | Application |
---|---|---|---|
NAB2105337SL | Mouse Anti-Human NLRP3 Monoclonal Antibody (CBP5787) | Mouse | IF; IHC; IP; WB |
NRZP-0922-ZP3526 | NeuroMab™ Anti-NLRP3 Antibody, Clone N25445 (CBP14837) | Rabbit | WB; IP |
NRZP-0922-ZP3527 | NeuroMab™ Anti-NLRP3 Antibody, Clone N13357 (CBP14838) | Rabbit | WB; IP |
NRZP-0323-ZP119 | NLRP3 Inflammasome Antibody Panel |
Cat. No | Product Name | Host | Application |
---|---|---|---|
NRZP-0922-ZP3525 | NeuroMab™ Anti-NLRC4 Antibody, Clone N16098 (CBP14836) | Rabbit | WB; IP |
Cat. No | Product Name | Host | Application |
---|---|---|---|
NRZP-0922-ZP1490 | NeuroMab™ Anti-AIM2 Antibody, Clone N15125 (CBP12801) | Rabbit | WB; IP |
NRZP-0922-ZP1491 | NeuroMab™ Anti-AIM2 Antibody, Clone N17161 (CBP12802) | Rabbit | WB; IP |
-
Immune Response
Immune response is a key pathological mechanism of SCI and determines the prognosis of the disease. When SCI occurs, local microglial reactions and the breakdown of the blood-spinal barrier allow blood-borne immune cells to enter the spinal cord. These cells release proinflammatory or immunomodulatory substances and contribute to the immune response. The immune response has always been thought to be harmful and detrimental to the repair of SCI. In the pathophysiology of SCI, all brain functioning cells exhibit pathogenic reactions, and neural cells and inflammatory cells communicate improperly. Understanding the pathogenic mechanism of SCI and identifying important regulatory targets will be aided by analyzing the response and communication mechanisms of these essential functional cells.
Fig.1 Schematic illustrating cellular changes following SCI1.
At Creative Biolabs, our objective is to assist our clients in acquiring the most recent antibodies required for SCI research. Should you require further information regarding SCI-related antibodies, we invite you to explore the related products below or to contact us directly. We will respond to your inquiry in a timely manner.
Reference
- Hu, Xiao, et al. "Spinal cord injury: molecular mechanisms and therapeutic interventions." Signal transduction and targeted therapy 8.1 (2023): 245.
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2275) (Cat#: NRP-0422-P2275)
- iNeuMab™ Anti-GD2 Antibody (NRZP-1222-ZP767) (Cat#: NRZP-1222-ZP767)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Anti-TREM2 Antibody (NRP-0422-P792) (Cat#: NRP-0422-P792)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P1760) (Cat#: NRP-0422-P1760)
- iNeuMab™ Anti-Amyloid Beta 1-15 Antibody (NRP-0422-P867) (Cat#: NRP-0422-P867)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- Green Fluorescent BACE1 Cell Lines (Cat#: NCL2110P214)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Mouse Microglia from C57BL/6 (Cat#: NCL-21P6-082)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- Human Retinal Epithelial Cell ARPE-19 (Cat#: NCL2110P069)
- Human Glial (Oligodendrocytic) Hybrid Cell Line (MO3.13) (Cat#: NCL-2108P34)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- ABCA1 Antisense Oligonucleotide (NV-2106-P27) (Cat#: NV-2106-P27)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Mouse Parkinson disease (autosomal recessive, early onset) 7 (Park7) (NM_020569) clone, Untagged (Cat#: NEP-0621-R0133)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)